Preparation and isolation of 5′ capped MRNA
View Patent ↗The synthesis of capped/tagged RNA, methods of use and kits providing same are contemplated. Tagged RNA permits isolation of RNA transcripts in vitro. The ability to isolate and purify capped RNA results in improved transcription and translation and provides a tool for identifying RNA-protein interactions. Such capped RNA finds use in therapeutic applications, diagnosis and prognosis and in the treatment of cancers and HIV.
1. A composition comprising:
wherein,
B is a nucleobase;
R 1 is selected from a halogen, OH, and OCH 3 ;
R 2 is selected from H, OH, and OCH 3 ;
R 3 is CH 3 or void;
R 4 is NH 2 ;
R 5 is H; and
n is 1, 2 or 3; and
wherein,
a linker is attached to one of R 1 , R 2 , R 4 , R 5 , or B.
2. The composition as recited in claim 1 , wherein said linker is selected from N, S, and O.
3. The composition as recited in claim 2 , wherein said linker is selected from an aminoallyl ([—CH 2 ] n CH 2 NH 2 ) where n=2-18, a secondary amine and an alkyl (C 3 -C 10 )NH 2 chain.
4. The composition as recited in claim 2 , further comprising a reporter moiety attached to said linker.
5. The composition as recited in claim 4 , wherein said reporter moiety is selected from an affinity tag and an epitope tag.
6. The composition as recited in claim 5 , wherein said affinity tag is selected from biotin, iminobiotin, avidin, and streptavidin.
7. The composition as recited in claim 6 , wherein said biotin is selected from C 5 -C 20 -biotin, SS-biotin, XX-biotin, and NHS ester compounds thereof.
8. The composition as recited in claim 1 , wherein
R 3 is void,
the nucleobase is selected from the group consisting of a pyrimidine, a pyrimidine nucleobase analog, a purine, a purine nucleobase analog, and natural, synthetic and derivative nucleobases thereof,
a) a linker is attached to one of the pyrimidine or purine nucleobases, and
b) a reporter moiety is attached to the linker.
9. The composition as recited in claim 8 , wherein said reporter moiety is an affinity tag selected from biotin, iminobiotin, avidin, and streptavidin.
10. The composition as recited in claim 8 attached to the 5′ end of an RNA molecule.
11. The composition as recited in claim 1 , wherein
R 3 is CH 3 ,
the nucleobase is selected from the group consisting of a pyrimidine, a pyrimidine nucleobase analog, a purine, a purine nucleobase analog, and natural, synthetic and derivative nucleobases thereof,
a) a linker is attached to one of the pyrimidine or purine nucleobases, and
b) a reporter moiety is attached to the linker.
12. The composition as recited in claim 11 , wherein said reporter moiety is an affinity tag selected from biotin, iminobiotin, avidin, and streptavidin.
13. The composition as recited in claim 11 attached to the 5′ end of an RNA molecule.
14. The composition as recited in claim 1 , wherein R 3 is CH 3 , the nucleobase is selected from the group consisting of a pyrimidine, a pyrimidine nucleobase analog, a purine, a purine nucleobase analog, and natural, synthetic and derivative nucleobases thereof,
a) a linker is attached to one of R 1 , R 2 , R 4 , or R 5 , and
b) a reporter moiety is attached to the linker.
15. The composition as recited in claim 14 , wherein said reporter moiety is an affinity tag selected from biotin, iminobiotin, avidin, and streptavidin.
16. The composition as recited in claim 14 attached to the 5′ end of an RNA molecule.
17. A method of synthesizing a dinucleotide cap analog comprising:
providing a guanosine nucleoside comprising either a 2′ substituent or a 3′ substituent and optionally comprising a linker;
phosphorylating the nucleoside, forming a nucleotide;
methylating the nucleotide;
adding a phosphorylated second nucleotide optionally comprising a linker;
coupling said first nucleotide with said second nucleotide, forming a dinucleotide cap analog.
18. A method for isolating a dinucleotide capped molecule comprising:
a) providing a nucleic acid mixture containing the composition as recited in claim 10 ;
b) binding the reporter moiety of step a) to a substrate;
c) extracting the complex of step b) from the nucleic acid mixture;
d) removing the linker from the capped nucleic acid; and
wherein capped nucleic acids are isolated.
19. A composition comprising:
an antigen presenting cell transfected with the composition of claim 1 .
20. A kit for capping an RNA transcript comprising a cap analog having the structure:
wherein,
B is a nucleobase;
R 1 is selected from a halogen, OH, and OCH 3 ;
R 2 is selected from OH, OCH 3 , and H;
R 3 is CH 3 or void;
R 4 is NH 2 ;
R 5 is H; and
n is 1, 2 or 3;
and wherein,
a linker is attached to one of R 1 , R 2 , R 4 , R 5 , or B;
a reporter moiety is attached to the linker;
at least R 1 , or R 2 is OH; and
b) an RNA polymerase.